As the promise of innovation reveals to us a future of more targeted therapies, advanced biologics, and potentially curative treatments, payers are struggling with how to manage and provide access to this influx of possibility for patients. In the past patients waited, today they must act. Access to and affordability of these treatments cannot be assumed. We once thought that having health coverage meant having access to all treatments. That is no longer the case. Now patients must be vigilant that those making decisions about access and affordability are putting patient voices at the forefront of the equation. This panel will bring forth actions and solutions around doing just that. Whether you work for a large or a small non-profit, or are simply a fierce patient advocate -- this panel will give you tips on how to engage, how to persuade, and how to rise up and make your voice heard in a sea of policy and economic mumbo jumbo.